These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 22207123)
1. Is lipoxins A₄ a better alternative to anti-VEGF and anti-TNF-α antibody to prevent and treat age-related macular degeneration, diabetic macular edema and retinopathy? Das UN Med Sci Monit; 2012 Jan; 18(1):LE1-2. PubMed ID: 22207123 [No Abstract] [Full Text] [Related]
2. Is lipoxins A4 a better alternative to anti-TNF-alpha antibody to prevent and treat diabetic macular edema and retinopathy? Das UN Med Sci Monit; 2010 Sep; 16(9):LE13-4. PubMed ID: 20802423 [No Abstract] [Full Text] [Related]
3. Lipoxins, resolvins, and protectins in the prevention and treatment of diabetic macular edema and retinopathy. Das UN Nutrition; 2013 Jan; 29(1):1-7. PubMed ID: 22677359 [TBL] [Abstract][Full Text] [Related]
4. VEGF inhibitors for AMD and diabetic macular edema. Med Lett Drugs Ther; 2015 Mar; 57(1464):41-2. PubMed ID: 25758545 [No Abstract] [Full Text] [Related]
5. [New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia]. Rejdak R; Szkaradek M; Taslaq W; Kałuzny JJ; Grieb P; Jünemann AG Klin Oczna; 2012; 114(4):308-10. PubMed ID: 23461161 [TBL] [Abstract][Full Text] [Related]
6. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema. Emerson MV; Lauer AK BioDrugs; 2007; 21(4):245-57. PubMed ID: 17628122 [TBL] [Abstract][Full Text] [Related]
7. [What can anti-VEGF therapy achieve in clinical routine? : Effectiveness of anti-VEGF therapy in patients with macular diseases in clinical routine on 1492 eyes in Austria]. Wiesinger K; Reinelt P; Ennemoser A; Edelmayr M; Schönherr U Ophthalmologe; 2017 Jul; 114(7):639-645. PubMed ID: 27815675 [TBL] [Abstract][Full Text] [Related]